Epidemiology of erectile dysfunction (part 2). Risk factors;Epidémiologie de la dysfonction érectile (2ème partie). Facteurs de risque

Andrologie

Volumn 12, Issue 4, 2002, Pages 323-331

  Delavierre, Dominique ^a  

^a CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

Author keywords

Epidemiology; Erectile dysfunction; Impotence; Prevalence

Indexed keywords

CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; COMORBIDITY; DIABETES MELLITUS; DYSLIPIDEMIA; ERECTILE DYSFUNCTION; HUMAN; HYPERTENSION; IMPOTENCE; PATHOPHYSIOLOGY; PREVALENCE; PSYCHOSOCIAL DISORDER; REVIEW; RISK FACTOR; SMOKING HABIT; SOCIOECONOMICS;

EID: 17544405034     PISSN: 11662654     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03034649     Document Type: Review

References (51)

1. ANSONG K.S., LEWIS C., JENKINS P., BELL J.: Epidemiology of erectile dysfunction: a community-based study in rural New York State. Ann. Epidemiol., 2000, 10: 293-296.
2. ARAUJO A.B., JOHANNES C.B., FELDMAN H.A., DERBY C.A., McKINLAY J.B.: Relation between psychosocial risk factors and incident erectile dysfunction: prospective results from the Massachusetts Male Aging Study. Am. J. Epidemiol., 2000, 152: 533-541.
3. AYTAC I.A., ARAUJO A.B., JOHANNES C.B., KLEINMAN K.P., McKINLAY J.B.: Socioeconomic factors and incidence of erectile dysfunction: findings of the longitudinal Massachussetts Male Aging Study. Soc. Sci. Med., 2000, 51: 771-778.
4. BARKSDALE J.D., GARDNER S.F.: The impact of first-line antihypertensive drugs on erectile dysfunction. Pharmacotherapy, 1999, 19: 573-581.
5. e Congrès de l'Association Française d'Urologie, 20-23 novembre 2002, Paris.
6. BORTOLOTTI A., FEDELE D., CHATENOUD L., et al.: Cigarette smoking: a risk factor for erectile dysfunction in diabetics. Eur. Urol., 2001, 40: 392-396.
7. BRAUN M., WASSMER G., KLOTZ T., REIFENRATH B., MATHERS M., ENGELMAN U.: Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int. J. Impot. Res., 2000, 12: 305-311.
8. BURCHARDT M., BURCHARDT T., BAER L. et al.: Hypertension is associated with severe erectile dysfunction. J. Urol., 2000, 164: 1188-1191.
9. CARSON C.C., PATEL M.P.: The epidemiology, anatomy, physiology, and treatment of erectile dysfunction in chronic renal failure patients. Adv. Ren. Replace. Ther., 1999, 6: 296-309.
10. CERQUEIRA J., MORAES M., GLINA S.: Erectile dysfunction: prevalence and associated variables in patients with chronic renal failure. Int. J. Impot. Res., 2002, 14: 65-71.
11. CHEW K.K., EARLE C.M., STUCKEY B.G., JAMROZIK K., KEOGH E.J.: Erectile dysfunction in general medicine practice: prevalence and clinical correlates. Int. J. Impot. Res., 2000, 12: 41-45.
12. CHUNG W.S., SOHN J.H., PARK Y.Y.: Is obesity an underlying factor in erectile dysfunction? Eur. Urol., 1999, 36: 68-70.
13. DERBY C.A., BARBOUR M.M., HUME A.L., McKINLAY J.B.: Drug therapy and prevalence of erectile dysfunction in the Massachusetts Male Aging Study cohort. Pharmacotherapy., 2001, 21: 676-683.
14. DERBY C.A., MOHR B.A., GOLDSTEIN I., FELDMAN H.A. JOHANNES CB, McKINLAY JB: Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk. Urology, 2000, 56: 302-306.
15. FEDELE D., COSCELLI C., CUCINOTTA D. et al.: Incidence of erectile dysfunction in Italian men with diabetes. J. Urol., 2001, 166: 1368-1371.
16. FEDELE D., COSCELLI C., SANTEUSANIO F. et al.: Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. Diabetes Care, 1998, 21: 1973-1977.
17. FELDMAN H.A., GOLDSTEIN I., HATZICHRISTOU D.G., KRANE R.J., McKINLAY J.B.: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J. Urol., 1994, 151: 54-61.
18. FELDMAN H.A., JOHANNES C.B., DERBY C.A. et al.: Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev. Med., 2000, 30: 328-338.
19. FRANKEL S.J., DONOVAN J.L., PETERS T.I. et al.: Sexual dysfunction in men with lower urinary tract symptoms. J. Clin. Epidemiol., 1998, 51: 677-685.
20. FRANZEN D., METHA A., SELFERT N., BRAUN M., HOPP H.W.: Effects of beta-blockers on sexual performance in men with coronary heart disease. A prospective, randomized and double blinded study. Int. J. Impot. Res., 2001, 13: 348-351.
21. GREENSTEIN A., CHEN J., MILLER H., MATZKIN H., VILLA Y., BRAF Z.: Does severity of ischemic coronary disease correlate with erectile function? Int. J. Impot. Res., 1997, 9:123-126.
22. GRIMM R.H. Jr, GRANDITS G.A., PRINEAS R., et al.: Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension, 1997, 29: 8-14.
23. GRUNBAUM A., KHALEEG-UR-REHMAN, CARRIER S.: Bicycling and erectile dysfunction: a review of the literature. J. Sex. Reprod. Med., 2002, 2: 75-79.
24. GUAY A.T., PEREZ J.B., HEAT G.J.: Cessation of smoking rapidly decreases erectile dysfunction. Endoc. Pract., 1998, 4: 23-26.
25. HAKIM L.S., GOLDSTEIN I.: Diabetic sexual dysfunction. Endocrinol. Metab. Clin. North Am., 1996, 25: 379-400.
26. JENSEN J., LENDORF A., STIMPEL H., FROST J., IBSEN H., ROSENKILDE P.: The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am. J. Hypertens., 1999, 12: 271-275.
27. JOHANNES C., ARAUJO A.B., FELDMAN H.A., DERBY C.A., McKINLAY J.B.: Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study. J. Urol., 2000, 163: 460-463.
28. KIM S.W., PAICK J., PARK D.W., CHAE I., OH B.: Potential predictors of asymptomatic ischemic heart disease in patients with vasculogenic erectile dysfunction. Urology, 2001, 58: 441-445.
29. KLEIN R., KLEIN B.E., LEE K.E., MOSS S.E., CRUICKSHANKS K.J.: Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care, 1996, 19: 135-141.
30. LAUMANN E.O., PAIK A., ROSEN R.C.: Sexual dysfunction in the United States: prevalence and predictors. J.A.M.A., 1999, 281: 537-544.
31. LEE I.C., SURRIDGE D., MORALES A., HEATON J.P.: The prevalence and influence of significant psychiatric abnormalities in men undergoing comprehensive management of organic erectile dysfunction. Int. J. Impot. Res., 2000, 12: 47-51.
32. ème Congrès de l'Association française d'urologie, Paris, 15-19 Novembre 2000, Résumé 03.
33. LEWIS R.W.: Epidemiology of erectile dysfunction. Urol. Clin. North Am., 2001, 28: 209-216.
34. McVAY K.T., CARRIER S., WESSELLS H.: Smoking and erectile dysfunction: evidence based analysis. J. Urol., 2001, 166: 1624-1632.
35. MALAVAUD B., ROSTAING L., RISCHMANN P., SARRAMON J.P., DURAND D.: High prevalence of erectile dysfunction after renal transplantation. Transplantation, 2000, 69: 2121-2124.
36. MANNINO D.M., KLEVENS R.M., FLANDERS W.D.: Cigarette smoking: an independent risk factor for impotence? Am. J. Epidemiol., 1994, 140: 1003-1008.
37. MARCEAU L., KLEINMAN K., GOLDSTEIN I., McKINLAY J.: Does bicycling contribute to the risk of erectile dysfunction? Results from the Massachusetts Male Aging Study (MMAS). Int. J. Impot. Res., 2001, 13: 298-302.
38. MARTIN-MORALES A., SANCHEZ-CRUZ J.J., SAENZ DE TEJADA I., RODRIGUEZ-VELA L., JIMENEZ-CRUZ J.F., BURGOS-RODRIGUEZ R.: Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfunction Erectil Masculina Study. J. Urol., 2001, 166: 569-574.
39. MEINHARDT W., KROPMAN R.F., VERMEIJ P., NIJEHOLT A.A., ZWARTENDIJK J.: The influence of medication on erectile function. Int. J. Impot. Res., 1997, 9: 17-26.
40. NETO A.F., DE FREITAS RODRIGUES M.A., SARAIVA FITTIPALDI J.A., MOREIRA E.D. Jr: The epidemiology of erectile dysfunction and its correlates in men with chronic renal failure on hemodialysis in Londrina, southern Brazil. Int. J. Impot. Res., 2002, 14 Suppl 2: 19-26.
41. O'KANE P.D., JACKSON G.: Erectile dysfunction: is there silent obstructive coronary artery disease? Int. J. Clin. Pract., 2001, 55: 219-220.
42. PARAZZINI F., MENCHINI FABRIS F., BORTOLLI A.: Frequency and determinants of erectile dysfunction in Italy. Eur. Urol., 2000, 37: 43-49.
43. PINNOCK C.B., STAPLETON A.M., MARSHALL V.R.: Erectile dysfunction in the community: a prevalence study. Med. J. Aust., 1999, 171: 353-357.
44. ROSAS S.E., JOFFE M., FRANKLIN E. et al.: Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int., 2001, 59: 2259-2266.
45. SAIRAM K., KULINSKAYA E., BOUSTEAD G.B., HANBURY D.C., McNICHOLAS T.A.: Prevalence of undiagnosed diabetes mellitus in male erectile dysfunction. Brit. J. Urol. Int., 2001, 88: 68-71.
46. SCHACHTER M.: Erectile dysfunction and lipid disorders. Curr. Med. Res. Opin., 2000, 16 Suppl 1: 9-12.
47. SIU S.C., LO S.K., WONG K.W., IP K.M., WONG Y.S.: Prevalence of and risk factors for erectile dysfunction in Hong Kong diabetic patients. Diabet. Med., 2001, 18: 732-738.
48. SULLIVAN M.E., MILLER M.A., BELL C.R. et al.: Fibrinogen, lipoprotein (a) and lipids in patients with erectile dysfunction. A preliminary study. Int. Angiol., 2001, 20: 195-199.
49. SULLIVAN M.E., THOMPSON C.S., DASHWOOD M.R. et al.: Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc. Res., 1999, 43: 658-665.
50. TENGS T.O., OSGOOD N.D.: The link between smoking and impotence: two decades of evidence. Prev. Med., 2001, 32: 447-526.
51. WEI M., MACERA C.A., DAVIS D.R., HORNUNG C.A., NANKIN H.R., BLAIR S.N.: Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am. J. Epidemiol., 1994, 140: 930-937.